scholarly journals Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials

BMJ ◽  
2005 ◽  
Vol 331 (7509) ◽  
pp. 134 ◽  
Author(s):  
Philip C Maier ◽  
Jens Funk ◽  
Guido Schwarzer ◽  
Gerd Antes ◽  
Yngve T Falck-Ytter
2021 ◽  
pp. bjophthalmol-2020-317262
Author(s):  
Paul Harasymowycz ◽  
Catherine Royer ◽  
Amy Xianying Cui ◽  
Martin Barbeau ◽  
Katherine Jobin-Gervais ◽  
...  

Background/aimsTo assess the comparative efficacy of latanoprostene bunod (LBN), a novel prostaglandin analogue (PGA), to other medications for open-angle glaucoma and ocular hypertension on lowering intraocular pressure (IOP).MethodsA systematic literature review adapted from the Li et al (Ophthalmology, 2016) study was conducted. Medline, Embase and PubMed were searched for randomised controlled trials published between 1 January 2014 and 19 March 2020. Studies had to report IOP reduction after 3 months for at least two different treatments among placebo, PGAs (bimatoprost 0.01%, bimatoprost 0.03%, latanoprost, LBN, tafluprost, unoprostone) or apraclonidine, betaxolol, brimonidine, brinzolamide, carteolol, dorzolamide, levobunolol, timolol, travoprost. A Bayesian network meta-analysis was performed to provide the relative effect in terms of mean difference (95% credible interval) of IOP reduction and ranking probabilities. Surface under the cumulative ranking curve (SUCRA) was generated.ResultsA total of 106 trials were included with data for 18 523 participants. LBN was significantly more effective than unoprostone (−3.45 (−4.77 to −2.12)). Although relative effect was not significative, compared with other PGAs, LBN numerically outperformed latanoprost (−0.70 (−1.83 to 0.43)) and tafluoprost (−0.41 (−1.87 to 1.07)), was similar to bimatoprost 0.01% (-0.02(−1.59 to 1.55)) and was slightly disadvantaged by bimatoprost 0.03% (−0.17 (−1.42 to 1.07)). LBN was significantly more efficient than the beta-blockers apraclonidine, betaxolol, brimonidine, brinzolamide, carteolol, dorzolamide and timolol. According to SUCRA, LBN was ranked second after bimatoprost 0.03%, followed by bimatoprost 0.01%.ConclusionLBN was significantly more effective than the PGA unoprostone and most of the beta-blockers. Compared with the most widely used PGAs, LBN numerically outperformed latanoprost and travoprost and was similar to bimatoprost 0.01%.


Eye ◽  
2019 ◽  
Vol 34 (1) ◽  
pp. 161-167 ◽  
Author(s):  
Richard Wormald ◽  
Gianni Virgili ◽  
Augusto Azuara-Blanco

2017 ◽  
Vol 101 (10) ◽  
pp. 1315-1317 ◽  
Author(s):  
Andrew Law ◽  
Kristina Lindsley ◽  
Benjamin Rouse ◽  
Richard Wormald ◽  
Kay Dickersin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document